Evidence map›Paper›PMID 30930730›Full record

ArticleFrontiers in neuroscience2019

Cholinergic Deficit Induced by Central Administration of 192IgG-Saporin Is Associated With Activation of Microglia and Cell Loss in the Dorsal Hippocampus of Rats.

Yulia V Dobryakova, Maria N Volobueva, Anna O Manolova, Tatiana M Medvedeva, Alexey A Kvichansky, Natalia V Gulyaeva, Vlamidir A Markevich, Mikhail Yu Stepanichev, Alexey P Bolshakov

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Reduction in hippocampal cholinergic neurostimulating peptide enhances memory impairment in AppAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Saporin fromToxins · 2020
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yulia V DobryakovaInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.
Maria N VolobuevaInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.
Anna O ManolovaInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.
Tatiana M MedvedevaInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.
Alexey A KvichanskyInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.
Natalia V GulyaevaInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.
Vlamidir A MarkevichInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.
Mikhail Yu StepanichevInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.
Alexey P BolshakovInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.
Institute of Higher Nervous Activity and Neurophysiology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is associated with degeneration of cholinergic neurons in the basal forebrain. Administration of the immunotoxin 192IgG-saporin to rats, an animal model of AD, leads to degeneration of cholinergic neurons in the medial septal area. In the present study, cholinergic cell death was induced by intracerebroventricular administration of 192IgG-saporin. One and a half months after injection, we studied the histopathology of the hippocampus and the responses of microglia and astrocytes using immunohistochemistry and neuroglial gene expression. We found that treatment with 192IgG-saporin resulted in neuronal loss in the CA3 field of the hippocampus. Microglial proliferation was observed in the dentate gyrus of the dorsal hippocampus and white matter. Massive proliferation and activation of microglia in the white matter was associated with strong activation of astrocytes. However, the expression of microglial marker genes significantly increased only in the dorsal hippocampus, not the ventral hippocampus. These effects were not related to non-specific action of 192IgG-saporin because of the absence of the Nerve growth factor receptor in the hippocampus. Additionally, 192IgG-saporin treatment also induced a decrease in the expression of genes that are associated with transport functions of brain vascular cells (Slc22a8, Ptprb, Sdpr), again in the dorsal hippocampus but not in the ventral hippocampus. Taken together, our data suggest that cholinergic degeneration in the medial septal area induced by intracerebroventricular administration of

Indexed as

192IgG-saporinCA3 areadorsal hippocampusmicrogliavascular endothelium

Identifiers

PMID30930730
PMCPMC6424051
OpenAlexW2911542248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.